Melanoma, Version 2.2016

被引：163

作者：

Coit, Daniel G. ^{[1
]}

Thompson, John A. ^{[2
]}

Algazi, Alain ^{[3
]}

Andtbacka, Robert ^{[4
]}

Bichakjian, Christopher K. ^{[5
]}

Carson, William E., III ^{[6
,7
]}

Daniels, Gregory A. ^{[8
]}

DiMaio, Dominick ^{[9
]}

Ernstoff, Marc ^{[10
,11
]}

Fields, Ryan C. ^{[12
,13
]}

Fleming, Martin D. ^{[14
]}

Gonzalez, Rene ^{[15
]}

Guild, Valerie ^{[16
]}

Halpern, Allan C. ^{[17
]}

Hodi, F. Stephen, Jr. ^{[18
]}

Joseph, Richard W. ^{[19
]}

Lange, Julie R. ^{[20
]}

Martini, Mary C. ^{[21
]}

Materin, Miguel A. ^{[22
]}

Olszanski, Anthony J. ^{[23
]}

Ross, Merrick I. ^{[24
]}

Salama, April K. ^{[25
]}

Skitzki, Joseph ^{[26
]}

Sosman, Jeff ^{[27
]}

Swetter, Susan M. ^{[28
]}

Tanabe, Kenneth K. ^{[29
]}

Torres-Roca, Javier F. ^{[30
]}

Trisal, Vijay ^{[31
]}

Urist, Marshall M. ^{[32
]}

McMillian, Nicole

Engh, Anita

机构：

[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

[2] Fred Hutchinson Canc Res Ctr, Seattle Canc Care Alliance, Seattle, WA USA

[3] UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA

[4] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA

[5] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA

[6] Ohio State Univ, Ctr Comprehens Canc, James Canc Hosp, Columbus, OH 43210 USA

[7] Solove Res Inst, Columbus, OH USA

[8] UC San Diego Moores Canc Ctr, San Diego, CA USA

[9] Fred & Pamela Buffett Canc Ctr, Omaha, NE USA

[10] Univ Hosp Seidman Canc Ctr, Case Comprehens Canc Ctr, Cleveland, OH USA

[11] Cleveland Clin, Taussig Canc Inst, Cleveland, OH USA

[12] Barnes Jewish Hosp, Siteman Canc Ctr, St Louis, MO USA

[13] Washington Univ, Sch Med, St Louis, MO 63130 USA

[14] Univ Tennessee, Hlth Sci Ctr, Knoxville, TN 37996 USA

[15] Univ Colorado, Ctr Canc, Boulder, CO 80309 USA

[16] Aim Melanoma, Houston, TX USA

[17] Mem Sloan Kettering Canc Ctr, New York, NY USA

[18] Dana Farber Brigham & Womens Canc Ctr, Boston, MA USA

[19] Mayo Clin, Ctr Canc, Rochester, MN USA

[20] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA

[21] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA

[22] Smilow Canc Hosp, Yale Canc Ctr, New Haven, CT USA

[23] Fox Chase Canc Ctr, Seattle, WA USA

[24] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

[25] Duke Canc Inst, Durham, NC USA

[26] Roswell Pk Canc Inst, Buffalo, NY USA

[27] Vanderbilt Ingram Canc Ctr, Nashville, TN USA

[28] Stanford Canc Inst, Stanford, CA USA

[29] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA

[30] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[31] City Hope Comprehens Canc Ctr, Duarte, CA USA

[32] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL USA

来源：

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2016年 / 14卷 / 04期

关键词：

ISOLATED LIMB PERFUSION; CARBON-DIOXIDE LASER; CUTANEOUS METASTATIC MELANOMA; COOPERATIVE-ONCOLOGY-GROUP; SENTINEL LYMPH-NODE; STAGE-III MELANOMA; HIGH-RISK MELANOMA; HIGH-DOSE INTERFERON-ALPHA-2B; BACILLUS-CALMETTE-GUERIN; IN-TRANSIT MELANOMA;

D O I：

10.6004/jnccn.2016.0051

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Melanoma focuses on adjuvant therapy and treatment of in-transit disease, because substantial changes were made to the recommendations for the 2016 update. Depending on the stage of the disease, options for adjuvant therapy now include biochemotherapy and high dose ipilimumab. Treatment options for in-transit disease now include intralesional injection with talimogene laherparepvec (T-VEC), a new immunotherapy. These additions prompted reassessment of the data supporting older recommended treatment options for adjuvant therapy and in-transit disease, resulting in extensive revisions to the supporting discussion sections.

引用

页码：450 / +

页数：17

共 165 条

[1] Randomized phase III trial of high-dose interferon alfa-2b (HDI) for 4 weeks induction only in patients with intermediate- and high-risk melanoma (Intergroup trial E 1697)
Agarwala, S. S.
Lee, S. J.
Flaherty, L. E.
Smylie, M.
Kefford, R. F.
Carson, W. E.
Cohen, G.
Kirkwood, J. M.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[2] The Benefits of Adjuvant. Radiation Therapy After Therapeutic Lymphadenectomy for Clinically Advanced, High-Risk, Lymph Node-Metastatic Melanoma
Agrawal, Shefali
Kane, John M., III
Guadagnolo, Beverly A.
Kraybill, William G.
Ballo, Matthew T.
[J]. CANCER, 2009, 115 (24) : 5836 - 5844
[3] Andtbacka RHI, 2015, ASCO M, V33
[4] Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
Andtbacka, Robert H. I.
Kaufman, Howard L.
Collichio, Frances
Amatruda, Thomas
Senzer, Neil
Chesney, Jason
Delman, Keith A.
Spitler, Lynn E.
Puzanov, Igor
Agarwala, Sanjiv S.
Milhem, Mohammed
Cranmer, Lee
Curti, Brendan
Lewis, Karl
Ross, Merrick
Guthrie, Troy
Linette, Gerald P.
Daniels, Gregory A.
Harrington, Kevin
Middleton, Mark R.
Miller, Wilson H., Jr.
Zager, Jonathan S.
Ye, Yining
Yao, Bin
Li, Ai
Doleman, Susan
VanderWalde, Ari
Gansert, Jennifer
Coffin, Robert S.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (25) : 2780 - U98
[5] Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases - A randomized controlled trial
Aoyama, Hidefumi
Shirato, Hiroki
Tago, Masao
Nakagawa, Keiichi
Toyoda, Tatsuya
Hatano, Kazuo
Kenjyo, Masahiro
Oya, Natsuo
Hirota, Saeko
Shioura, Hiroki
Kunieda, Etsuo
Inomata, Taisuke
Hayakawa, Kazushige
Katoh, Norio
Kobashi, Gen
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (21): : 2483 - 2491
[6] Combination therapy of imiquimod and gentian violet for cutaneous melanoma metastases
Arbiser, Jack L.
Bips, Maria
Seidler, Anne
Bonner, Michael Y.
Kovach, Charles
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 67 (02) : E81 - E83
[7] Final Version of 2009 AJCC Melanoma Staging and Classification
Balch, Charles M.
Gershenwald, Jeffrey E.
Soong, Seng-jaw
Thompson, John F.
Atkins, Michael B.
Byrd, David R.
Buzaid, Antonio C.
Cochran, Alistair J.
Coit, Daniel G.
Ding, Shouluan
Eggermont, Alexander M.
Flaherty, Keith T.
Gimotty, Phyllis A.
Kirkwood, John M.
McMasters, Kelly M.
Mihm, Martin C., Jr.
Morton, Donald L.
Ross, Merrick I.
Sober, Arthur J.
Sondak, Vernon K.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (36) : 6199 - 6206
[8] Isolated Limb Infusion for Malignant Melanoma: Predictors of Response and Outcome
Barbour, Andrew P.
Thomas, Janine
Suffolk, Jennifer
Beller, Elaine
Smithers, B. Mark
[J]. ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (12) : 3463 - 3472
[9] RADIATION THERAPY FIELD EXTENT FOR ADJUVANT TREATMENT OF AXILLARY METASTASES FROM MALIGNANT MELANOMA
Beadle, Beth M.
Guadagnolo, B. Ashleigh
Ballo, Matthew T.
Lee, Jeffrey E.
Gershenwald, Jeffrey E.
Cormier, Janice N.
Mansfield, Paul F.
Ross, Merrick I.
Zagars, Gunar K.
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 73 (05): : 1376 - 1382
[10] A Multi-Institutional Experience of Isolated Limb Infusion: Defining Response and Toxicity in the US
Beasley, Georgia M.
Caudle, Abigail
Petersen, Rebecca P.
McMahon, Nicole S.
Padussis, James
Mosca, Paul J.
Zager, Jonathan S.
Hochwald, Steven N.
Grobmyer, Stephen R.
Delman, Keith A.
Andtbacka, Robert H.
Noyes, R. Dirk
Kane, John M.
Seigler, Hilliard
Pruitt, Scott K.
Ross, Merrick I.
Tyler, Douglas S.
[J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2009, 208 (05) : 706 - 715

← 1 2 3 4 5 6 7 8 9 10 →